SCHEMBL5228967

SCHEMBL5228967

CC1CCN(C(C)(C)CO)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PHGDH O43175 1/20 0.39
MGLL Q99685 1/20 0.39
ALDH1A1 P00352 3/20 0.36
NPC1 O15118 2/20 0.36
CYP1A2 P05177 1/20 0.36
ACHE P22303 3/20 0.33
CARM1 Q86X55 1/20 0.33
PRMT6 Q96LA8 1/20 0.33
PRMT1 Q99873 1/20 0.33
PRMT8 Q9NR22 1/20 0.33
POLB P06746 1/20 0.32
HTT P42858 1/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
TSHR P16473 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
MAPK11 Q15759 1/20 0.31
MAPK14 Q16539 1/20 0.31
SIGMAR1 Q99720 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12422222 0.79 PHGDH (0.35) PHGDHMGLLALDH1A1NPC1ACHE
Hydrochloric Acid SCHEMBL17796060 0.78 GNAI3 (0.36) CYP1A2MAPK11MAPK14
SCHEMBL12424262 0.77 PHGDH (0.34) PHGDHMGLLALDH1A1NPC1ACHE
SCHEMBL29214439 0.77 HTT (0.34) PHGDHMGLLALDH1A1NPC1ACHE
SCHEMBL6219635 0.77 NCF1 (0.48) CYP1A2HTTCHRM3
SCHEMBL12837952 0.76 CYP1A2 (0.31) CYP1A2
SCHEMBL19440696 0.76 PHGDH (0.33) PHGDHMGLLALDH1A1NPC1ACHE
SCHEMBL26433905 0.75 ALDH1A1 (0.40) ALDH1A1NPC1POLBHTTMEN1
SCHEMBL23896486 0.74 ACHE (0.39) PHGDHMGLLALDH1A1NPC1ACHE
SCHEMBL23277743 0.73 CYP1A2 (0.42) CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1737824-A2 NOVEL ALKYNE COMPOUNDS HAVING AN MCH-ANTAGONISTIC EFFECT, AND MEDICAMENTS CONTAINING SAID COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-01-03 EP disclosed
US-20050245529-A1 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-03 US disclosed
WO-2005103032-A2 NOVEL ALKYNE COMPOUNDS HAVING AN MCH-ANTAGONISTIC EFFECT, AND MEDICAMENTS CONTAINING SAID COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245529-A1 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds MCHR1, GPR119, MCHR2 PHGDH 4434/4885MGLL 411/4885ALDH1A1 3033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.